Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Ramanujam

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Neuroimmunology|June 6, 2008
PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravisAnn Kari Lefvert, Yaofeng Zhao, Ryan Ramanujam, et al.
Journal of Clinical Immunology|October 17, 2009
IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotypeJavad Mohammadi, Ryan Ramanujam, Sara Jarefors, et al.
JAMA Neurology|September 9, 2015
Effect of Smoking Cessation on Multiple Sclerosis PrognosisRyan Ramanujam, Anna-Karin Hedström, Ali Manouchehrinia, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2023
The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case-control studyGraysen Steele Boles, Jan Hillert, Ryan Ramanujam, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 3, 2019
Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort studyLoes Crielaard, Andrius Kavaliunas, Ryan Ramanujam, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 4, 2012
Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practiceRoger Jungedal, Malin Lundkvist, Elin Engdahl, et al.
Brain : a Journal of Neurology|January 21, 2014
Modest familial risks for multiple sclerosis: a registry-based study of the population of SwedenHelga Westerlind, Ryan Ramanujam, Daniel Uvehag, et al.
Human Immunology|March 26, 2014
HLA-A(∗)02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6Elin Engdahl, Rasmus Gustafsson, Ryan Ramanujam, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2016
Importance of early treatment initiation in the clinical course of multiple sclerosisAndrius Kavaliunas, Ali Manouchehrinia, Leszek Stawiarz, et al.
Multiple Sclerosis and Related Disorders|May 4, 2022
Short report: Real-life analysis of the occurrence of persistent, transient, and fluctuating positive titres of neutralizing anti-drug antibodies in multiple sclerosis patients treated with interferon betaMatilde Oviedo Querejazu, Nicky Dunn, Ryan Ramanujam, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Neuroimmunology|June 6, 2008
PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravisAnn Kari Lefvert, Yaofeng Zhao, Ryan Ramanujam, et al.
Journal of Clinical Immunology|October 17, 2009
IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotypeJavad Mohammadi, Ryan Ramanujam, Sara Jarefors, et al.
JAMA Neurology|September 9, 2015
Effect of Smoking Cessation on Multiple Sclerosis PrognosisRyan Ramanujam, Anna-Karin Hedström, Ali Manouchehrinia, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2023
The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case-control studyGraysen Steele Boles, Jan Hillert, Ryan Ramanujam, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 3, 2019
Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort studyLoes Crielaard, Andrius Kavaliunas, Ryan Ramanujam, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 4, 2012
Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practiceRoger Jungedal, Malin Lundkvist, Elin Engdahl, et al.
Brain : a Journal of Neurology|January 21, 2014
Modest familial risks for multiple sclerosis: a registry-based study of the population of SwedenHelga Westerlind, Ryan Ramanujam, Daniel Uvehag, et al.
Human Immunology|March 26, 2014
HLA-A(∗)02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6Elin Engdahl, Rasmus Gustafsson, Ryan Ramanujam, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2016
Importance of early treatment initiation in the clinical course of multiple sclerosisAndrius Kavaliunas, Ali Manouchehrinia, Leszek Stawiarz, et al.
Multiple Sclerosis and Related Disorders|May 4, 2022
Short report: Real-life analysis of the occurrence of persistent, transient, and fluctuating positive titres of neutralizing anti-drug antibodies in multiple sclerosis patients treated with interferon betaMatilde Oviedo Querejazu, Nicky Dunn, Ryan Ramanujam, et al.
Pageof 3